Mental Help Net
Morphine, Blood Thinner Plavix a Bad Mix for Heart Attack Victims: Study
Morphine appears to reduce the effectiveness of the commonly used blood-thinning drug Plavix, which could hamper emergency-room efforts to treat heart attack victims, Austrian researchers report.
Wed Nov 27, 2013
Clinicians Receive Some Support to Tweak Stent-Related Antiplatelet Therapy
The OPTIMIZE study randomized 3211 patients to 3 or 12 months of clopidogrel 75 mg/day.
Tue Nov 26, 2013
Maintenance of perioperative antiplatelet and anticoagulant therapy for vitreoretinal surgery
Background The objective of this study was to prospectively assess the risk of bleeding from vitreoretinal surgery in a continuous unbiased cohort of patients taking unsuspended antiplatelet or anticoagulant therapy.
Mon Nov 25, 2013
CHANCE Trial: Early Short-Term Dual Antiplatelet Treatment for Stroke ...
From the Department of Neurology, The University of North Carolina at Chapel Hill ; and Department of Neurology, Medizinische Hochschule Hannover, Hannover, Germany .
FDA Spanks 23andMe, Grants Breakthrough Status To Factor Xa...
It was a busy morning at the FDA. Three new FDA actions may be of considerable interest in the cardiology universe: FDA Halts 23andMe Personal Genome Test- The FDA sent a scathing letter to 23andMe ordering the company to stop selling its Personal Genome Service test.
Sat Nov 23, 2013
Clopidogrel with aspirin in acute minor stroke or transient ischemic attack.
The New England journal of medicine , Vol. 369, No. 1. , pp. 11-19, doi:10.1056/nejmoa1215340 Stroke is common during the first few weeks after a transient ischemic attack or minor ischemic stroke.
Tue Nov 19, 2013
NorthShore University HealthSystem Partners With Mayo Clinic to Study ...
Which antiplatelet medication is best after a coronary stent? The costly and potential life-or-death question lingers after most of the 600,000 angioplasties performed every year in the United States.
Mon Nov 18, 2013
Heart attack survival similar among those receiving clot-busting drugs, angioplasty
One-year survival rates after severe heart attack are similar among patients who initially receive clot-busting medications and those who undergo angioplasty.
Sat Nov 16, 2013
Medical News Today
Genetic testing for cardiovascular therapy 'underutilized'
Welcome to the new MNT ! See what's new , or send feedback . By the way, it's our 10th birthday ! Creating a free account will enable you to subscribe to our daily and weekly email newsletters, as well as customize your reading experience to show only the categories most relevant to you.
Wed Nov 13, 2013
Mayo Clinic Studying Genomics of Antiplatelet Heart Medication
ROCHESTER, Minn. -- Which antiplatelet medication is best after a coronary stent? The costly and potential life-or-death question lingers after most of the 600,000 angioplasties performed every year in the United States.
Thu Nov 07, 2013
Uncertainty Prevails For AstraZeneca
Questions regarding the unusually high death rates in heart patients consuming AstraZeneca's Brilinta and the associated side effects has caused the US Federal Drug and Administration regulators to investigate the drug and its approval process undertaken two years ago.